Autopsy report · NCT00571467

Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP

“Terminated due to recruitment not meeting expectations.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 3 months before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Protalex, Inc.

Sponsor type

Industry

Conditions

Idiopathic Thrombocytopenic Purpura (ITP)

Interventions

PRTX-100 (Staphylococcal protein A)

Participants

9

Sites

7

Countries

Australia, New Zealand

Trials that died the same way

• Prontosan Quality of Life Study in Patients With Chronic Leg Wound(s)
  “Terminated due to prolonged subject recruitment” (82% match in meaning)
• Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
  “Terminated because of slow recruitment and lack of funding support” (82% match in meaning)
• Cromoglicate in Mastocytosis
  “prematurely terminated because of low recruitment” (81% match in meaning)
• Teens Coping With Parental Military Deployment
  “Terminated due to difficuly recruiting participants” (81% match in meaning)
• Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients
  “terminated due to very low recruitment rate (27 June 2006)” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.